Author

Michael William Lawlor

Medical College of WisconsinORCID 0000-0003-0731-3950Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1

Frequent Co-Authors

Atul S. DeshmukhiD· 2 shared Edmar ZanoteliiD· 2 shared Julien OchalaiD· 2 shared Roger Moreno‐JusticiaiD· 2 shared Alexia Van de LoockiD· 1 shared Anneleen Weyns· 1 shared Ben StocksiD· 1 shared Christopher T. A. LewisiD· 1 shared

Activity by Year

2023-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

Atul S. DeshmukhORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

PhysiologyThe Journal of PhysiologyPeer-reviewedMay 1, 2025

Integrated single cell functional-proteomic profiling of human skeletal muscle reveals a shift in cellular specificity in nemaline myopathy

Robert A. E. Seaborne, Roger Moreno‐Justicia, Jenni M. Laitila…·Julien Ochala

This paper introduces SMPFO, a method combining fluorescence assays and proteome profiling to study skeletal muscle, revealing reduced myofiber subtype divergence in nemaline myopathy.

5 citations

humanproteomics

𝕏 PostBluesky

GeneticsbioRxivPreprintDec 20, 2023

Characterization of NEB mutations in patients reveals novel nemaline myopathy disease mechanisms and omecamtiv mecarbil force effects

Esmat Karimi, Mila van der Borgh, Johan Lindqvist…·Henk L. M. Granzier

This study characterizes NEB mutations in NEM2 patients, revealing mechanisms of nebulin dysfunction and the potential therapeutic benefit of Omecamtiv mecarbil.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky

PhysiologybioRxivSep 7, 2023

Human skeletal muscle fiber heterogeneity beyond myosin heavy chains

Roger Moreno-Justicia, Thibaux Van der Stede, Ben Stocks…·Atul S. Deshmukh

This study identifies sources of skeletal muscle fiber heterogeneity beyond myosin heavy chains using transcriptomic and proteomic data from human muscle fibers.

DOI 10.1038/s41467-025-56896-6

humanscRNA-seq

𝕏 PostBluesky